Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Helicobacter pylori surface components and enzymes encompass a diverse array of proteins essential for the bacterium's colonization, survival, and pathogenesis within the human stomach. A primary component is the enzyme urease, which catalyzes the hydrolysis of urea into ammonia and carbon dioxide, effectively neutralizing local gastric acid to protect the organism [1, 5]. Surface-exposed adhesins, such as the blood group antigen-binding adhesin (BabA) and sialic acid-binding adhesin (SabA), facilitate persistent colonization by binding to specific receptors on the gastric epithelium [2]. Furthermore, H. pylori utilizes specialized secretion systems to deliver virulence factors like the vacuolating cytotoxin A (VacA) and the cytotoxin-associated gene A (CagA) protein into host cells, where they disrupt cellular signaling and induce inflammation [3]. These components are the primary drivers of diseases such as chronic gastritis, peptic ulcers, and gastric adenocarcinoma [4]. While these factors are essential for the H. pylori lifecycle, they are generally targeted by broad-spectrum antibiotics and proton pump inhibitors rather than specific individual inhibitors, though urease remains a target for bismuth-based compounds [1, 4]. [1] NIH StatPearls: Helicobacter Pylori; [2] PubMed: Mobley HL, et al.; [3] PubMed: Cover TL, et al.; [4] Mayo Clinic: H. pylori infection; [5] UniProt: Urease subunit alpha.
Inhibition of bacterial urease activity, disruption of bacterial cell wall synthesis, inhibition of protein synthesis, and reduction of gastric acidity to enhance antibiotic efficacy.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Helicobacter pylori surface components and enzymes (H. pylori surface components/enzymes).